Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRADICARDIA study of ivabradine for microvascular complications in type 2 diabetes mellitus
ACTRN12618002056279Phase 2Completed
- Sponsor
- Royal Perth Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ivabradine in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Royal Perth Hospital. Primary endpoint: Change in urinary albumin creatinine ratio. Started Jan 2021; status: completed.
02
Drugs
ivabradine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ACTRN12618002056279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618002056279.